Dana L. Schalk - Concepedia

Author

Dana L. Schalk

The Barbara Ann Karmanos Cancer Institute ORCID

Also Known As

Dana L Schalk, Dana L. Schalk, Dana Schalk

143

Publications

689

Citations

H-Index

Concepts

All Affiliations

The Barbara Ann Karmanos Cancer Institute Wayne State University University of Virginia The Wistar Institute University of Virginia Cancer Center

About

Dana L. Schalk is an author at The Barbara Ann Karmanos Cancer Institute specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	293
2	Immunology	4	4	293
3	Cell Biology	3	3	182
4	Allergy	1	1	111
5	Neurology	1	1	113

Dana L. Schalk

Publications

632

Citations

H-Index

Page 1

	Year	Citations
B cells from patients with multiple sclerosis induce cell death via apoptosis in neurons in vitro Robert P. Lisak, Liljana Nedelkoska, Joyce A. Benjamins, Journal of Neuroimmunology MedicineApoptosisImmunologyB CellsCell Death	2017	113
Targeted delivery of siRNA to activated T cells via transferrin-polyethylenimine (Tf-PEI) as a potential therapy of asthma Yuran Xie, Venkatareddy Nadithe, Dana L. Schalk, Journal of Controlled Release AsthmaNanomedicineCell-based Drug DeliveryAllergyT Cells	2016	111
Clinical and immune responses to anti-CD3 x anti-EGFR bispecific antibody armed activated T cells (EGFR BATs) in pancreatic cancer patients Lawrence G. Lum, Archana Thakur, Minsig Choi, OncoImmunology	2020	56
A Th1 cytokine–enriched microenvironment enhances tumor killing by activated T cells armed with bispecific antibodies and inhibits the development of myeloid-derived suppressor cells Archana Thakur, Dana L. Schalk, Sanila H. Sarkar, Cancer Immunology Immunotherapy Activated T CellsTumor ImmunologyMicroenvironment Enhances TumorCancer ImmunosurveillanceImmunology	2011	50
CD20-Targeted T Cells after Stem Cell Transplantation for High Risk and Refractory Non-Hodgkin's Lymphoma Lawrence G. Lum, Archana Thakur, Qin Liu, Biology of Blood and Marrow Transplantation	2013	39
Preferential expression of functional IL-17R in glioma stem cells: potential role in self-renewal Prahlad Parajuli, Rohit Anand, Chandramouli Mandalaparty, Oncotarget	2016	36
Microenvironment generated during EGFR targeted killing of pancreatic tumor cells by ATC inhibits myeloid-derived suppressor cells through COX2 and PGE2 dependent pathway Archana Thakur, Dana L. Schalk, Elyse N. Tomaszewski, Journal of Translational Medicine	2013	33
Phase II clinical trial using anti-CD3 × anti-HER2 bispecific antibody armed activated T cells (HER2 BATs) consolidation therapy for HER2 negative (0–2+) metastatic breast cancer Lawrence G. Lum, Zaid Al‐Kadhimi, Abhinav Deol, Journal for ImmunoTherapy of Cancer	2021	32
Phase II Trial of Pembrolizumab and Anti-CD3 x Anti-HER2 Bispecific Antibody-Armed Activated T Cells in Metastatic Castration-Resistant Prostate Cancer Ulka N. Vaishampayan, Archana Thakur, Wei Chen, Clinical Cancer Research	2022	28
Maspin expression in prostate tumor elicits host anti-tumor immunity Sijana H. Dzinic, Kang Chen, Archana Thakur, Oncotarget	2014	23

Page 1